Metrics as of 10/13/2026, 06:51 PM (Berlin time), refresh in progress.
Outset Medical Stock
Outset Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Leslie L. Trigg
- Employees
- 310
- Market cap
- $74 M
- IPO
- 15/09/2020
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts…
Outset Medical stock: price history
1D
-2.3%
1W
-5.8%
1M
+25.9%
6M
-8.9%
YTD
+6.9%
1Y
-70.4%
2Y
-55.8%
5Y
-99.5%
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~142% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Outset Medical
Analyst assessment of Outset Medical
PRICE TARGET LOW
US$6.00
CONSENSUS
US$14.00
MEDIAN
US$8.00
PRICE TARGET HIGH
US$34.00
0
STRONG BUY
7
BUY
3
HOLD
1
SELL
0
STRONG SELL
11
TOTAL · Buy
As of: 12/02/2026
Outset Medical stock metrics
P/E
-0.97
P/B
0.77
EV/EBITDA
-2.51
RETURN ON EQUITY
-18.7%
NET MARGIN
-56.8%
DEBT/EQUITY
1.08
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
83.6%
FLOAT SHARES
15,496,392
AVG. DAILY VOLUME (30D)
181,542
Insider transactions (SEC)
Leonard Braden Michael
Leonard Braden Michael
Trigg Leslie
Brottem John L.
Gaeta Renee
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Outset Medical stock
What does Outset Medical do?
Outset Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Leslie L. Trigg, the company employs around 310 people.
The IPO was on 15/09/2020; the stock trades on NASDAQ under the ticker OM.
What do analysts say about Outset Medical stock?
11 analysts rate the stock, the consensus is Buy (as of 12/02/2026).
The average price target is US$14.00, ranging from US$6.00 to US$34.00, with a median of US$8.00.
This is an external assessment, not a statement by Market Jury.
When does Outset Medical report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 142% stronger than usual.
Does Outset Medical pay a dividend?
No, Outset Medical currently does not pay a dividend.
Which stocks are comparable to Outset Medical?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Outset Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Outset Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.